Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)].
Takeshita A, Ohno R, Hirashima K, Toyama K, Okuma M, Saito H, Ikeda Y, Tomonaga M, Asano S. Takeshita A, et al. Among authors: hirashima k. Rinsho Ketsueki. 1995 Jun;36(6):606-14. Rinsho Ketsueki. 1995. PMID: 7543956 Clinical Trial. Japanese.
Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group.
Bessho M, Hirashima K, Asano S, Ikeda Y, Ogawa N, Tomonaga M, Toyama K, Nakahata T, Nomura T, Mizoguchi H, Yoshida Y, Niitsu Y, Kohgo Y. Bessho M, et al. Among authors: hirashima k. Eur J Haematol. 1997 Apr;58(4):265-72. doi: 10.1111/j.1600-0609.1997.tb01665.x. Eur J Haematol. 1997. PMID: 9186538 Clinical Trial.
Multicenter prospective study of clonal complications in adult aplastic anemia patients following recombinant human granulocyte colony-stimulating factor (lenograstim) administration.
Bessho M, Hotta T, Ohyashiki K, Takahashi T, Mizoguchi H, Asano S, Ikeda Y, Sakurai M, Tojo A, Kizaki M, Iwanaga M, Tomonaga M, Hirashima K. Bessho M, et al. Among authors: hirashima k. Int J Hematol. 2003 Feb;77(2):152-8. Int J Hematol. 2003. PMID: 12627850 Clinical Trial.
[Therapeutic evaluation of combination therapy using human native immunoglobulin preparation for i.v. administration, with antibiotics and G-CSF in severe infections in the field of internal medicine].
Kitamura K, Mizoguchi H, Hirashima K, Asano S, Toyama K, Ikeda Y, Takaku F. Kitamura K, et al. Among authors: hirashima k. Kansenshogaku Zasshi. 1995 Jun;69(6):684-95. doi: 10.11150/kansenshogakuzasshi1970.69.684. Kansenshogaku Zasshi. 1995. PMID: 7542300 Clinical Trial. Japanese.
Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases.
Toyama K, Yaguchi M, Mizoguchi H, Masuda M, Urabe A, Ikeda Y, Aoki I, Shinbo T, Togawa A, Hirashima K, Miura Y, Hirose S, Tsuruoka N, Omine M, Kamakura M, Saito T, Arimori S, Aoki N, Kuraishi Y, Hirai H, Asano S, Mori M, Shirai T, Muto Y, Takaku F, et al. Toyama K, et al. Among authors: hirashima k. Kansenshogaku Zasshi. 1996 Dec;70(12):1242-53. doi: 10.11150/kansenshogakuzasshi1970.70.1242. Kansenshogaku Zasshi. 1996. PMID: 9011117 Clinical Trial.
251 results